AIA
GILD icon

Aventus Investment Advisors’s Gilead Sciences GILD Stock Holding History

Aventus Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16K Buy
+25
New +$3.29K ﹤0.01% 144
2025
Q3 		– Sell
-10
Closed -$1.11K – 149
2025
Q2 		$1.11K Buy
+10
New +$1.06K ﹤0.01% 150

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Aventus Investment Advisors's GILD Position: Q2 2026 in Review

Aventus Investment Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 25 shares worth $3.16K. The stake represents ﹤0.01% of the portfolio and ranks #144 among its holdings. This is a return to the name: Aventus Investment Advisors previously reported a position in GILD as recently as Q2 2025.

Aventus Investment Advisors first reported a position in GILD in Q2 2025 and has held it in 2 quarters since. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aventus Investment Advisors held 25 shares of Gilead Sciences worth $3.16K as of Q2 2026.
  • Gilead Sciences was a new Aventus Investment Advisors position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Aventus Investment Advisors's portfolio in Q2 2026, its #144 holding.
  • Aventus Investment Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 2 quarters since.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aventus Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.